Specific inhibition of CD4+ T lymphocytes by a hybrid antibody

Nature Biotechnology
Y Qi, U D Staerz

Abstract

T lymphocytes are crucial in the defense against foreign intruders and cancerous growths. Yet, in circumstances such as transplantation or autoimmunity, T-cell-mediated responses can be detrimental. Inhibition of these deleterious responses is currently achieved by drugs that induce general immune suppression. These compounds also impair the patient's defenses against infections. Strategies are now being sought that induce selective rather than generalized immune unresponsiveness. One such strategy is the ability to inhibit the activation of CD8+ T lymphocytes. As CD4+ T lymphocytes similarly participate in graft rejection and in autoimmune diseases, we have now developed a reagent to delete their activity. It comprises CD4 and an anti-MHC class II antibody. By virtue of the antibody's specificity for MHC class II molecules, this hybrid antibody (Hab) binds to class II molecules, thereby bringing CD4 accessory molecules to the surface of class II-bearing stimulator cells where they occupy CD4 binding sites on class II molecules. As a consequence CD4+ T cells with specificity to Hab-coated stimulator cells cannot engage their CD4 molecules and are no longer activated. This Hab technology provides a strategy to offer specific rat...Continue Reading

References

Mar 1, 1992·The Journal of Experimental Medicine·K HirumaR E Gress
Nov 1, 1992·The Journal of Experimental Medicine·H KosakaJ Sprent
Jan 1, 1991·Annual Review of Immunology·G T Nepom, H Erlich
Nov 1, 1991·The Journal of Experimental Medicine·O RötzschkeH G Rammensee
Oct 1, 1990·Immunological Reviews·J Sprent, M Schaefer
Jan 1, 1990·International Immunology·J E HamborD R Kaplan
May 1, 1989·International Reviews of Immunology·H G Rammensee
Jan 7, 1988·Nature·A TrauneckerK Karjalainen
Apr 18, 1985·Nature·U D StaerzM J Bevan
Mar 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·U D Staerz, M J Bevan
Dec 1, 1988·Nature·F Zepp, U D Staerz
May 1, 1986·Transplantation·S Cobbold, H Waldmann
Apr 1, 1987·European Journal of Immunology·U D StaerzM J Bevan
Jun 1, 1993·The Journal of Experimental Medicine·Z LiuN Suciu-Foca
Dec 1, 1993·Current Opinion in Immunology·A O'Garra, K Murphy
May 1, 1996·The Journal of Experimental Medicine·Y QiU D Staerz
Nov 1, 1996·The Journal of Experimental Medicine·C P LiuP Marrack

❮ Previous
Next ❯

Citations

Mar 31, 2000·Immunology Today·U D StaerzY Qi
Oct 31, 2001·Clinical Immunology : the Official Journal of the Clinical Immunology Society·S RaoM J Holterman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.